URGN
UroGen Pharma Ltd. · Healthcare · Biotechnology
Données momentum (gérants comparables) :
étendue des détenteurs -10.0% ·
flux d'actions +12.7% ·
nouvelles positions nettes -11.1%
— formule
Accumulation concentrée — hausse des parts chez un moins grand nombre de détenteurs
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q3 2025
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | +11 | 16.33M | $599.97M | +14 | −3 |
| Q1 2026 | 68 | -2 | 16.64M | $299.41M | +7 | −9 |
| Q4 2025 | 71 | 0 | 16.74M | $392.08M | — | — |
| Q3 2025 | 18 | -2 | 12.72M | $253.85M | — | −2 |
| Q2 2025 | 17 | +1 | 7.27M | $99.60M | +1 | — |
| Q1 2025 | 13 | 0 | 4.33M | $47.90M | — | — |
| Q4 2024 | 13 | +2 | 6.43M | $68.46M | +2 | — |
| Q3 2024 | 10 | -2 | 7.92M | $100.53M | — | −2 |
| Q2 2024 | 12 | — | 7.91M | $132.72M | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passif) | 2.58M | +7.3% | $51.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Morgan Stanley ✦ | 2.53M | — | $50.44M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 2.53M | — | $50.44M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 2.53M | — | $50.44M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 2.53M | — | $50.44M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 2.53M | — | $50.44M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 2.53M | — | $50.44M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 2.53M | — | $50.44M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 1.47M | +147.2% | $29.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 1.07M | — | $21.33M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 888.93K | +3140.5% | $17.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (passif) | 819.45K | +1.5% | $16.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 602.28K | +10.9% | $12.02M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 602.28K | +10.9% | $12.02M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | Geode Capital Management ✦ (passif) | 471.23K | +0.1% | $9.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 34 | Geode Capital Management ✦ (passif) | 471.23K | +0.1% | $9.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 35 | Goldman Sachs Group ✦ | 424.92K | — | $8.48M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 424.92K | — | $8.48M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 386.20K | +103.9% | $7.70M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 356.62K | -1.3% | $7.12M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | T. Rowe Price ✦ | 356.62K | -1.3% | $7.12M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | The Vanguard Group ✦ (passif) | 303.79K | +19.1% | $6.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | The Vanguard Group ✦ (passif) | 303.79K | +19.1% | $6.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | The Vanguard Group ✦ (passif) | 303.79K | +19.1% | $6.06M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 43 | Renaissance Technologies ✦ | 275.10K | +620.2% | $5.49M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 204.19K | -11.8% | $4.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 204.19K | -11.8% | $4.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 204.19K | -11.8% | $4.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 204.19K | -11.8% | $4.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 204.19K | -11.8% | $4.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 49 | ARK Investment Management ✦ | 126.72K | -23.7% | $2.53M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 50 | Wellington Management ✦ | 125.30K | -20.7% | $2.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 51 | Wellington Management ✦ | 125.30K | -20.7% | $2.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 52 | Wellington Management ✦ | 125.30K | -20.7% | $2.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 53 | Fidelity (FMR) ✦ | 73.12K | +2959.2% | $1.46M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 54 | Fidelity (FMR) ✦ | 73.12K | +2959.2% | $1.46M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 55 | Marshall Wace ✦ | 18.68K | -9.6% | $372,566 | 0.0% | ▼ Trim | 4 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Aucun nouvel acheteur suivi ce trimestre. |
Sorti(e)
| Adage Capital Partners | $11.37M | était 0.0% |
| Point72 Asset Management | $2.31M | était 0.0% |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 171 détenteurs, 46.40M actions, $801.72M déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.